Nektar Therapeutics (NKTR)
37.68
+2.32
(+6.56%)
USD |
NASDAQ |
Jan 16, 16:00
37.70
+0.02
(+0.05%)
Pre-Market: 20:00
Nektar Therapeutics Shareholders Equity (Quarterly): 85.09M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Rigel Pharmaceuticals, Inc. | 117.61M |
| Insmed, Inc. | 945.57M |
| Eli Lilly & Co. | 23.79B |
| Ironwood Pharmaceuticals, Inc. | -264.16M |
| Lyell Immunopharma, Inc. | 329.12M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 301.35M |
| Total Liabilities (Quarterly) | 216.26M |
| Debt to Equity Ratio | 1.964 |
| Current Ratio | 4.241 |
| Net Debt Paydown Yield | 1.07% |